The most important topic on the United State’s Supreme Court docket for the term may be the case of a musician from Vermont who lost an arm after a medical injection that went horrible wrong. At stake in the suit against Wyeth Pharmaceuticals is whether drug manufacturers are immune from claims they have faced from customers in thousands of cases, that the product label, despite approval by the U.S. Food and Drug Administration, failed to warn the buyer about all known side effects. The ruling should show the court’s stance on business regulation and consumer protection but also its views on the relationship between the states and the federal government. The federal government sets labeling standards. To read the full story, click here.